Orpea SA (ORP):企業の財務・戦略的SWOT分析

◆英語タイトル:Orpea SA (ORP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH34935FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse syndromes, anxiety disorders, addiction, and psychosis forms, among others. Orpea also provides retirement homes for independent seniors, semi-invalid and dependent communities, among others. The company provides suite care services such as acute episode of a chronic disease, postoperative trauma treatment, and accident care services, among others. It has its operations in Germany, Spain, Italy and Switzerland. Orpea is headquartered in Paris, Ile-de-France, France.

Orpea SA Key Recent Developments

Feb 09,2021: Orpea: Solid growth in Q4 2020 revenue: +6.4% to €1,017m
Jan 26,2021: ORPEA: 5 innovative projects rewarded at the ORPEA Excellence Awards 2020 & 3 Winners of the “1000 smiles” prize
Sep 22,2020: ORPEA : H1 2020: Business and profitability strongly resilient
Jul 28,2020: The therapeutic building in Skolkovo will begin accepting patients already in 2021
Jul 21,2020: ORPEA: Resilient H1 2020 revenue: +3.5% (€1,904 million)

This comprehensive SWOT profile of Orpea SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Orpea SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Orpea SA – Key Information
Orpea SA – Overview
Orpea SA – Key Employees
Orpea SA – Key Employee Biographies
Orpea SA – Key Operational Heads
Orpea SA – Major Products and Services
Orpea SA – History
Orpea SA – Company Statement
Orpea SA – Locations And Subsidiaries
Orpea SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Orpea SA – Business Description
Orpea SA – Corporate Strategy
Orpea SA – SWOT Analysis
SWOT Analysis – Overview
Orpea SA – Strengths
Orpea SA – Weaknesses
Orpea SA – Opportunities
Orpea SA – Threats
Orpea SA – Key Competitors

Section 3 – Company Financial Performance Charts

Orpea SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Orpea SA, Key Information
Orpea SA, Key Ratios
Orpea SA, Share Data
Orpea SA, Major Products and Services
Orpea SA, History
Orpea SA, Key Employees
Orpea SA, Key Employee Biographies
Orpea SA, Key Operational Heads
Orpea SA, Other Locations
Orpea SA, Subsidiaries
Orpea SA, Key Competitors
Orpea SA, SWOT Analysis
Orpea SA, Ratios based on current share price
Orpea SA, Annual Ratios
Orpea SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Orpea SA (ORP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OTK GROUP, a.s.:企業の戦略・SWOT・財務情報
    OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report Summary OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats. It relies on natural immune response and state of the art B cell cloning techniques for the produc …
  • Memphasys Ltd (MEM)-医療機器分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析
    JSFC Sistema (AFKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Science Applications International Corp
    Science Applications International Corp - Strategy, SWOT and Corporate Finance Report Summary Science Applications International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • U-Haul International Inc:企業の戦略的SWOT分析
    U-Haul International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Reins International Inc.:企業の戦略・SWOT・財務情報
    Reins International Inc. - Strategy, SWOT and Corporate Finance Report Summary Reins International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Oil-Dri Corporation of America (ODC):企業の財務・戦略的SWOT分析
    Summary Oil-Dri Corporation of America (Oil-Dri) is a manufacturer and supplier of sorbent products. The company offers granular clay absorbents, universal absorbent products, oil only absorbents, haz mat, socks and boom, spill kits, sweeping compounds, and secondary containment products. Its univer …
  • Checkpoint Surgical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Checkpoint Surgical Inc (Checkpoint Surgical) is a medical device company that offers neuro-protective surgical devices. The company’s products include checkpoint stimulators and locators; and checkpoint head and neck systems. Its checkpoint stimulators and locators provide biphasic stimulat …
  • Itochu Corp (8001):石油・ガス:M&Aディール及び事業提携情報
    Summary Itochu Corp (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, insurance …
  • IntegraGen SA (ALINT):製薬・医療:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • Redington (India) Ltd (REDINGTON):企業の財務・戦略的SWOT分析
    Redington (India) Ltd (REDINGTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • McBride plc (MCB):企業の財務・戦略的SWOT分析
    McBride plc (MCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sonali Bank Limited:企業の戦略・SWOT・財務情報
    Sonali Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Sonali Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CME Group Inc:企業の戦略・SWOT・財務情報
    CME Group Inc - Strategy, SWOT and Corporate Finance Report Summary CME Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • BioMoti Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BioMoti Ltd (BioMoti) is a pharmaceutical company that offers cancer therapeutics that develops platform drug delivery technologies. The company provides products such as Oncojans a class of immunotherapeutic drug-loaded particles to target and gain entry into the tumour vasculature and canc …
  • The Quizno’s Master LLC:企業の戦略・SWOT・財務情報
    The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report Summary The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Capital Group Companies, Inc.:企業の戦略・SWOT・財務情報
    The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • H.I.S. Co Ltd:企業の戦略・SWOT・財務分析
    H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • PDL BioPharma Inc (PDLI):製薬・医療:M&Aディール及び事業提携情報
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆